Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels

Circulation

Volumn 96, Issue 5, 1997, Pages 1454-1460

  Van Belle, Eric ^b   Bauters, Christophe ^b   Hubert, Edouard ^b   Bodart, Jean Christophe ^b   Abolmaali, Kaveh ^b   Meurice, Thibaud ^b   McFadden, Eugène P ^b   Lablanche, Jean Marc ^b   Bertrand, Michel E ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Angioplasty; Diabetes mellitus; Restenosis; Stents

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; STENT;

EID: 0030876311     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1454     Document Type: Article

References (37)

1. Hambly RI, Sherman L, Mehta J, Aintablian A. Reappraisal of the role of the diabetic state in coronary artery disease. Chest. 1976;70: 251-257.
2. Frein FS, Scheuer J. Heart disease in diabetes. In: Rifkin H, Porte D Jr, eds. Ellenberg and Rifkin's Diabetes Mellitus Theory and Practice. New York, NY: Elsevier Science Publishing Corp; 1990: 812-823.
3. Alderman EL, Andrews K, Bost J, Bourassa M, Chaitman BR, Detre K Faxon DP, Follman D, Frye RL, Hlatky M, Jones RH, Kelsey SF, Rogers WJ, Rosen AD, Hartzell S, Sellers MA, Sopko G, Sutton Tyrell K, Williams DO. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.
4. Rensing BJ, Hermans WRM, Vos J, Tijssen JGP, Rutch W, Danchin N, Heyndrickx GR, Mast EG, Wijns W, Serruys PW, on behalf of the Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group. Luminal narrowing after percutaneous transluminal coronary angioplasty: a study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Circulation. 1993;88:975-985.
5. Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, Van Raden MJ, Mock MB. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart/Lung, and Blood Institute. Am J Cardiol. 1984; 53:77C-81C.
6. Weintraub WS, Kosinski AS, Brown CL, King SB. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 1993;21:6-14.
7. Quigley PJ, Hlatky MA, Hinohara T, Rendall DS, Perez JA, Phillips HR, Califf RM, Stack RS. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol. 1989;63:409-413.
8. Lambert M, Bonan R, Côté G, Crépeau J, De Guise P, Lespérance J. David PR, Waters DD. Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis. J Am Coll Cardiol. 1988;12:310-314.
9. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996; 27:528-535.
10. Fischman DL, Leon MB, Baim DS. Schatz RA. Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
11. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Van Den Heuvel P, Delcan J, Morel M-A. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
12. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LL, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:1247-1254.
13. Bauters C, McFadden EP, Lablanche JM, Quandalle P, Bertrand ME. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site: a quantitative angiographic study in consecutive patients undergoing a third angioplasty for a second restenosis. Circulation. 1993;88:969-974.
14. Bauters C, Khanoyan P, McFadden EP, Quandalle P, Lablanche JM, Bertrand ME. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis. Circulation. 1995;91:1410-1418.
15. Bauters C, Lablanche JM, McFadden EP, Hamon M, Bertrand ME. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. Circulation. 1995;92:2473-2479.
16. Hamon M, Bauters C, Amant C, McFadden EP, Helbecque N, Lablanche JM, Bertrand ME, Amouyel P. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation. 1995;92:296-299.
17. Hamon M, Amant C, Bauters C, Lablanche JM, Bertrand ME, Amouyel P. ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am J Cardiol. 1996;78:679-681.
18. Lablanche JM, McFadden EP, Bonnet JL, Grollier G, Danchin N, Bedossa M, Leclercq C, Vahanian A, Bauters C, Van Belle E, Bertrand ME. Combined antiplatelet therapy with ticlopidine and aspirin: a simplified approach to intracoronary stent management. Eur Heart J. 1996;17:1373-1380.
19. The Thrombolysis In Myocardial Infarction (TIMI) Study Group. The Thrombolysis In Myocardial Infarction (TIMI) Trial. N Engl J Med. 1985;312:932-936.
20. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL. Guidelines for percutaneous transluminal coronary angioplasty: a report of the AHA/ACC Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 1988;12:529-545.
21. Bertrand ME, Lablanche JM, Bauters C, Leroy F, McFadden EP. Discordant results of visual and quantitative estimates of stenosis severity before and after coronary angioplasty. Cathet Cardiovasc Diagn. 1993;28:1-6.
22. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW, for the investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-1825.
23. Foley JB, Penn IM, Brown RIG, Murray-Parsons N, White J, Galligan L, MacDonald C. Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single center. Am Heart J. 1993;125:686-694.
24. Carroza JP Jr, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993;118:344-349.
25. Hearn JA, King SB III, Douglas JS Jr, Carlin SF, Lembo NJ, Ghazzal MB. Clinical and angiographic outcomes after coronary stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty: initial results with a balloon-expandable, stainless steel design. Circulation. 1993;88:2086-2096.
26. Ellis SG, Savage M, Fischman D, Baim DS, Leon M, Goldberg S, Hirshfeld JW, Cleman MW, Teirstein PS, Walker C, Bailey S, Buchbinder M, Topol EJ, Schatz RA. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Circulation. 1992; 86:1836-1844.
27. MacRury S, Lowe G. Blood rheology in diabetes mellitus. Diabet Med. 1990;7:285-291.
28. Ostermann H, van der Loo J. Factors of the hemostatic system in diabetic patients. Haemostasis. 1986;16:386-416.
29. Davi G, Catalano I, Averna M, Notobartolo A, Stano A, Ciabottoni G. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322:1769-1774.
30. Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ. Unstable angina: a comparison of angioscopic findings between diabetic and nondiabetic patients. J Am Coll Cordial. 1995;92:1731-1736.
31. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996-1002.
32. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
33. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and in the hypercholesterolemic Yucatan micropig. Circulation. 1994; 89:2816-2821.
34. Mintz GS, Popma JJ, Pichard AD, Kent SM, Satler LF, Wong SC, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
35. Murcia AM, Fallon JT, Fuster V. Smooth muscle cell proliferation does not account for restenosis in diabetic patients. Circulation. 1996;94(suppl I):I-619. Abstract.
36. Schomig A, Neuman FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 1996;334:1084-1089.
37. Foley JB, Brown RIG, Penn IM. Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting. Am Heart J. 1994;128:12-20.